Longevity.Technology: Cambrian Biopharma – CEO James Peyer Q&A

8

min read

23

Mar

21

“Longevity biotech exclusive Q&A with Cambrian Biopharma’s CEO, James Peyer – a discussion of the Hallmarks of Aging and classifying aging as a disease.”